Blood tester, a non-invasive screening option Shield - Brand name or equal will be considered.

The contract solicits 120 units of The Shield™ blood tester, a non-invasive screening tool FDA-approved for colorectal cancer detection in individuals at average risk, with brand-name or equal alternatives accepted. The procurement covers a base quantity of 120 units with an option to extend for four additional years, assuming annual usage of 20 units, for a potential total of 200 units over five years. Proposals must include pricing for the entire potential period, and the Government will evaluate offers based on technical acceptability, past performance using PPIRS and FAPIIS data, and total contract value, applying a trade-off process to identify the best value rather than selecting solely on lowest price. Performance is required at the Elko Service Unit in Nevada, with delivery terms implied to be FOB Destination, and all payments must be submitted electronically through the Invoice Processing Platform in compliance with OMB and HHSAR requirements. The contract incorporates a comprehensive set of Federal Acquisition Regulation clauses addressing labor standards, equal opportunity, employment eligibility, trafficking prevention, privacy, cybersecurity, and subcontracting, including prohibitions against contracting with Kaspersky Lab and inverted domestic corporations. Offerors must be registered in SAM.gov, hold a valid Unique Entity Identifier and CAGE Code, and complete all required representations regarding size status and socioeconomic certifications. Clauses related to non-displacement of workers, paid sick leave, minimum wage compliance, and reporting of executive compensation and first-tier subcontracts must be flowed down to subcontracts. While no specific packaging, marking, or technical specifications beyond FDA approval are detailed, acceptance is governed by Government inspection at the delivery point and adherence to commercial item standards under FAR Part 12. The solicitation closes on May 10, 2026, and responses must be submitted electronically through SAM.gov.